NASDAQ:NAKA KindlyMD (NAKA) Stock Price, News & Analysis $5.00 0.00 (0.00%) As of 11/13/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About KindlyMD Stock (NASDAQ:NAKA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get KindlyMD alerts:Sign Up Key Stats Today's Range$4.85▼$5.7350-Day Range$5.00▼$10.0552-Week Range$3.33▼$25.22Volume250,561 shsAverage Volume176,633 shsMarket Capitalization$91.75 millionP/E RatioN/ADividend YieldN/APrice Target$20.00Consensus RatingModerate Buy Company Overview KindlyMD is a Utah-based healthcare company that provides outpatient medical services, with a focus on integrated care. Its offerings include primary care, behavioral health and treatment for substance use disorders, along with care coordination intended to connect patients with appropriate services. The company serves patients through clinics in Utah and has emphasized care for people with complex or ongoing health needs. KindlyMD combined with Nakamoto Holdings in 2025; the resulting company trades on Nasdaq under the symbol NAKA.AI Generated. May Contain Errors. Read More KindlyMD Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks83rd Percentile Overall ScoreNAKA MarketRank™: 4.16600423953 of 5 starsKindlyMD scored higher than 83% of companies evaluated by MarketBeat, and ranked 434th out of 850 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingKindlyMD has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialKindlyMD has a consensus price target of $20.00, representing about 300.0% upside from its current price of $5.00.Amount of Analyst CoverageKindlyMD has only been the subject of 2 research reports in the past 90 days.Read more about KindlyMD's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for KindlyMD are expected to grow in the coming year, from ($12.94) to ($1.91) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of KindlyMD is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of KindlyMD is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKindlyMD has a P/B Ratio of 0.11. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted7.48% of the float of KindlyMD has been sold short.Short Interest Ratio / Days to CoverKindlyMD has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in KindlyMD has recently decreased by 10.21%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldKindlyMD does not currently pay a dividend.Dividend GrowthKindlyMD does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.95 News SentimentKindlyMD has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Finance companies.News Coverage This WeekMarketBeat has tracked 3 news articles for KindlyMD this week, compared to 1 article on an average week.MarketBeat Follows1 people have added KindlyMD to their MarketBeat watchlist in the last 30 days. Company Ownership3.6 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $227,738.00 in company stock, which represents 0.2482% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, KindlyMD insiders have bought 3,039.34% more of their company's stock than they have sold. Specifically, they have bought $235,231.00 in company stock and sold $7,493.00 in company stock.Percentage Held by Insiders24.08% of the stock of KindlyMD is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsKindlyMD has minimal institutional ownership at this time.Read more about KindlyMD's insider trading history. Receive NAKA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KindlyMD and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NAKA Stock News HeadlinesKindlyMD (NASDAQ:NAKA) Stock Rating Upgraded by Wall Street ZenNovember 14 at 1:19 AM | americanbankingnews.comHyperion DeFi (NASDAQ:HYPD) and KindlyMD (NASDAQ:NAKA) Critical ContrastNovember 5, 2026 | americanbankingnews.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount. | Base Camp Trading (Ad)Nakamoto Reports Second Quarter 2026 Financial and Operating ResultsAugust 13, 2026 | businesswire.comNakamoto Launches Intelligence 2027, a New Flagship Event for the AI EconomyAugust 12, 2026 | businesswire.comNasdaq-listed firm makes a drastic move to go all in on BitcoinJune 24, 2026 | thestreet.comClear Street Executes First Bitcoin Depositary Receipt Trade Through Prime Brokerage PlatformJune 23, 2026 | globenewswire.comNakamoto Announces Closing of Legacy Healthcare ClinicsJune 22, 2026 | businesswire.comSee More Headlines NAKA Stock Analysis - Frequently Asked Questions How have NAKA shares performed this year? KindlyMD's stock was trading at $14.0440 at the start of the year. Since then, NAKA shares have decreased by 64.4% and is now trading at $5.00. How were KindlyMD's earnings last quarter? KindlyMD, Inc. (NASDAQ:NAKA) issued its quarterly earnings data on Friday, November, 13th. The company reported $4.07 EPS for the quarter, beating analysts' consensus estimates of ($0.49) by $4.56. The company earned -$1.93 million during the quarter. KindlyMD had a negative trailing twelve-month return on equity of 73.53% and a negative net margin of 1,067.93%. When did KindlyMD's stock split? Shares of KindlyMD reverse split before market open on Friday, May 22nd 2026.The 1-40 reverse split was announced on Wednesday, May 20th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 21st 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of KindlyMD? Shares of NAKA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of KindlyMD own? Based on aggregate information from My MarketBeat watchlists, some other companies that KindlyMD investors own include Dragonfly Energy (DFLI), Datavault AI (DVLT), Lithium Americas (LAC), Advanced Micro Devices (AMD), Bitfarms (BITF), Bit Digital (BTBT) and Greenland Mines Ltd. Common Stock (GRML). Company Calendar Last Earnings11/13/2026Today11/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 NAKA's financial health is in the Green zone, according to TradeSmith. NAKA has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Financial Services Sub-IndustryMulti-Sector Holdings Current SymbolNASDAQ:NAKA Previous SymbolNASDAQ:NAKA CIK1946573 Webkindlymd.com Phone(385) 388-8220FaxN/AEmployeesN/AYear Founded2019Price Target and Rating Average Price Target for KindlyMD$20.00 High Price Target$30.00 Low Price Target$13.00 Potential Upside/Downside+300.0%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($35.85) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$52.23 million Net Margins-1,067.93% Pretax Margin-733.28% Return on Equity-73.53% Return on Assets-46.28% Debt Debt-to-Equity Ratio0.18 Current Ratio0.23 Quick Ratio0.23 Sales & Book Value Annual Sales$1.82 million Price / Sales50.41 Cash FlowN/A Price / Cash FlowN/A Book Value$46.97 per share Price / Book0.11Miscellaneous Outstanding Shares18,350,000Free Float13,928,000Market Cap$91.75 million OptionableOptionable Beta16.03 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:NAKA) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment t...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredGlobal Industrial Powerhouse Taps Nasdaq Drone MicrocapA Nasdaq-listed drone company just signed an exclusive agreement with Prime Strategic Holdings, part of billio...The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KindlyMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KindlyMD With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.